{
    "eid": "2-s2.0-85170362730",
    "title": "Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization",
    "cover-date": "2023-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Clinical Biochemistry",
            "@code": "1308",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "hepatitis B virus",
        "hepatocellular carcinoma",
        "microRNAs",
        "transarterial chemoembolization"
    ],
    "authors": [
        "Nutcha Pinjaroen",
        "Piyawan Chailapakul",
        "Supachaya Sriphoosanaphan",
        "Natthaya Chuaypen",
        "Pisit Tangkijvanich"
    ],
    "citedby-count": 0,
    "ref-count": 40,
    "ref-list": [
        "Hepatocellular carcinoma",
        "Epidemiology of viral hepatitis and hepatocellular carcinoma",
        "Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma",
        "Transarterial chemoembolization: Modalities, indication, and patient selection",
        "Switching to systemic therapy after locoregional treatment failure: Definition and best timing",
        "Management of hepatocellular carcinoma: An update",
        "Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score",
        "Viruses, microRNAs, and host interactions",
        "Diversifying microRNA sequence and function",
        "microRNAs: Key players in virus-associated hepatocellular carcinoma",
        "MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases",
        "Non-coding RNAs in hepatocellular carcinoma: Molecular functions and pathological implications",
        "miR-122--a key factor and therapeutic target in liver disease",
        "miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo",
        "Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma",
        "Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets",
        "MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma",
        "miR-221 silencing blocks hepatocellular carcinoma and promotes survival",
        "Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance",
        "MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma",
        "Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis",
        "Circulating microRNA profiles in plasma: Identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function",
        "Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224",
        "Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update",
        "Prognostic value of miR-221 in human malignancy: Evidence from 3041 subjects",
        "Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma",
        "miR-221 overexpression contributes to liver tumorigenesis",
        "Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro",
        "MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality",
        "Diagnostic implication of a circulating serum-based three-microRNA signature in hepatocellular carcinoma",
        "Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma",
        "MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View",
        "Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma",
        "Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis",
        "MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion",
        "Serum miR-335 Level is Associated with the Treatment Response to Trans-Arterial Chemoembolization and Prognosis in Patients with Hepatocellular Carcinoma",
        "Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization",
        "Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization",
        "Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival",
        "Circulating MiRNA-373 as a Predictor of Response to Super-selective Transarterial Chemoembolization Bridging Therapy in Hepatocellular Carcinoma Patients Awaiting Liver Transplantation"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Center of Excellence in Hepatitis and Liver Cancer",
        "Program Management Unit for Human Resources & Institutional Development, Research and Innovation",
        "Chulalongkorn University"
    ]
}